Drug Profile
Research programme: follicle stimulating hormone modulators - Pfizer
Latest Information Update: 16 Mar 2022
Price :
$50
*
At a glance
- Originator Arena Pharmaceuticals
- Class Small molecules
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Infertility
Most Recent Events
- 11 Mar 2022 Arena Pharmaceuticals has been acquired and merged into Pfizer
- 16 Jul 2016 No recent reports of development identified for preclinical development in Infertility in USA
- 10 Apr 2006 Preclinical trials in Infertility in USA (unspecified route)